Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.
about
Staphylococcal manipulation of host immune responsesWhere does a Staphylococcus aureus vaccine stand?Neutrophil-Mediated Phagocytosis of Staphylococcus aureusLack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret modelA Structurally Dynamic N-terminal Helix Is a Key Functional Determinant in Staphylococcal Complement Inhibitor (SCIN) ProteinsDiversity in the C3b Convertase Contact Residues and Tertiary Structures of the Staphylococcal Complement Inhibitor (SCIN) Protein FamilyStaphylococcus aureus CymR Is a New Thiol-based Oxidation-sensing Regulator of Stress Resistance and Oxidative ResponseOn the Functional Overlap between Complement and Anti-Microbial PeptidesSpatiotemporal dynamics of complement C5a production within bacterial extracellular polymeric substanceLipopolysaccharide as an antigen target for the formulation of a universal vaccine against Escherichia coli O111 strains.Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b.The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertaseExploring host-pathogen interactions through genome wide protein microarray analysisThe rickettsial OmpB β-peptide of Rickettsia conorii is sufficient to facilitate factor H-mediated serum resistanceComplement inhibition by Sarcoptes scabiei protects Streptococcus pyogenes - An in vitro study to unravel the molecular mechanisms behind the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions.Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapy.Progress and Trends in Complement TherapeuticsRecurrent infections and immune evasion strategies of Staphylococcus aureus.Humoral innate immune response and disease.Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells.The T Cell Response to Staphylococcus aureusCollagen-binding microbial surface components recognizing adhesive matrix molecule (MSCRAMM) of Gram-positive bacteria inhibit complement activation via the classical pathwayHijacking Complement Regulatory Proteins for Bacterial Immune Evasion.The giant protein Ebh is a determinant of Staphylococcus aureus cell size and complement resistance.Pertussis: a matter of immune modulation.New frontiers in meningococcal vaccines.Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteins.Challenges for a universal Staphylococcus aureus vaccine.Current insights in invasive group A streptococcal infections in pediatrics.Host- and microbe determinants that may influence the success of S. aureus colonization.Peptidoglycan hydrolases-potential weapons against Staphylococcus aureusPleiotropic virulence factor - Streptococcus pyogenes fibronectin-binding proteins.Parasitic scabies mites and associated bacteria joining forces against host complement defence.Novel Evasion Mechanisms of the Classical Complement Pathway.Binding of Streptococcus pneumoniae endopeptidase O (PepO) to complement component C1q modulates the complement attack and promotes host cell adherence.Borrelia burgdorferi Manipulates Innate and Adaptive Immunity to Establish Persistence in Rodent Reservoir Hosts.Soluble membrane attack complex is diagnostic for intraventricular shunt infection in children.Statins enhance formation of phagocyte extracellular traps.Exploitation of complement regulatory proteins by Borrelia and Francisella.The structural basis for inhibition of the classical and lectin complement pathways by S. aureus extracellular adherence protein.
P2860
Q26798461-ECF4DDDA-82FF-4DF0-BA1A-FCAE8E15AD40Q26828726-DEC0AD1C-3560-4268-94AB-E071C7D75CA7Q27025128-B18519DE-A16B-4C07-A8A8-9381FFDEB6A5Q27317179-4B651DD4-0061-4B99-B5FE-336D8DC8B297Q27675451-2800DE06-BAC2-4495-BAB6-37FFB445AD96Q27675598-BF5161D6-A706-4C1B-8947-981DB9AD7B1BQ27678878-00B4B4CC-E8CE-4B9B-B94A-AB449268FEAFQ28082379-3B7E5543-8D61-42EA-9641-ECA166B3AA68Q33894669-FB927922-58A7-43C1-9B39-C83E8C120FC6Q34289818-0E4EF0BF-C122-4B06-B07E-1513B0E1E4E1Q34448332-C62027D4-AE9E-44C8-8585-F8AD3C5BED85Q34647356-FAAA5BA2-EBC4-4E90-8634-325DEFC008D7Q36052418-C727AA2D-F152-4552-B55A-C30777CF7E2AQ36211176-853EFBA0-9572-45DB-824F-EDAD63E78A35Q36302638-D2C945ED-8099-4F7C-AC93-9D05A2ABD005Q36463266-45D4972F-55AF-4C5F-9F54-49E6814E8E12Q36479278-17BB347F-1B03-4D6F-B3B5-7874C5BF6D2BQ36513761-36BCB468-B571-45AF-85BD-E7E6B50A58B6Q36623129-A8B062B6-873A-4320-9AC4-578CB73646F1Q36718021-6E9458F4-CE17-44D5-ADE6-180F2BD1D853Q36735452-EEF4439A-0FDE-4175-BA70-7CB51C78827CQ37012489-744A8440-98CF-48AD-8B0E-1873D040E70AQ37516016-757050A5-A181-488B-B220-ECAE8D3DEF11Q37643393-0BC09133-05EB-48EE-B273-03FC473A7FE9Q37825920-F6F94F35-BE26-43EF-A5FA-F919EB4FBB0DQ37878480-5032C007-9182-4552-8230-BC3F0B2E5CA1Q37938945-AB5E93BC-7ED0-44F5-BB7D-04F2DC9004D4Q37987099-9F2C1774-41C7-444D-A4A6-83D6F42688D4Q37988376-C51478AA-7CE1-4753-BD0A-288E907724B0Q38037555-A5C9F992-3AD4-4B22-98AF-D333ACE5502FQ38053102-972A6943-BA74-4C12-8FA7-79EE8625036CQ38063278-7EFC509C-61A4-4CF9-9E74-C99360FE0CD5Q38235740-1A9E0BB8-312A-45F5-984A-7C9F507E23DAQ38824720-CD6DA931-7D57-46A0-AEBF-D6F1FDF4041BQ39003448-00962706-AEFE-4636-9D71-3A2123B48F04Q39164585-42BB7B7E-456A-4DE3-96F4-507DF3ED0536Q40518032-AA7DB38B-47C5-4ABE-B38A-7BD2CD95722EQ41426439-40CAA2ED-18F0-4F0E-ACC7-0AB239B7DBAAQ46737549-A7919A11-2441-4B8C-B781-AAD2E3DB27B0Q50997128-02A83E5E-7E68-49A3-9FF0-3E6275BBB858
P2860
Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Complement inhibition by gram- ...... and therapeutic implications.
@en
Complement inhibition by gram- ...... and therapeutic implications.
@nl
type
label
Complement inhibition by gram- ...... and therapeutic implications.
@en
Complement inhibition by gram- ...... and therapeutic implications.
@nl
prefLabel
Complement inhibition by gram- ...... and therapeutic implications.
@en
Complement inhibition by gram- ...... and therapeutic implications.
@nl
P2093
P2860
P921
P1476
Complement inhibition by gram- ...... and therapeutic implications.
@en
P2093
Alexander Laarman
Fin Milder
Jos van Strijp
Suzan Rooijakkers
P2860
P2888
P304
P356
10.1007/S00109-009-0572-Y
P577
2010-02-01T00:00:00Z